Filter By Industry
Filter By Tag

Newsroom

TRIGR Therapeutics, Inc. Press releases

1 - 1 of 1 Press Release

Dec 23, 2018
TRIGR Therapeutics, Inc. ("TRIGR"), a privately held biotechnology company focused on the clinical development and commercialization of bispecific antibody therapeutics for oncology and ophthalmology indications, announced that it will present at Biotech.


TRIGR Therapeutics, Inc. RSS Feed